TrimRx vs Push Health: Complete 2026 Comparison

Introduction

Push Health and TrimRx work in different shapes of telehealth. Push Health connects patients directly with individual licensed providers who set their own pricing. TrimRx runs a structured weight loss program with set monthly pricing and an in-house clinical team.

That structural difference drives everything else. Pricing, consistency, provider relationship, and clinical support all flow from whether you’re shopping individual clinicians or buying a packaged program.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is Push Health and How Does It Work?

Push Health is a telehealth marketplace where patients connect with individual licensed providers for prescription requests, lab orders, and limited consultations. Providers set their own pricing for visits, which can range from $30 to over $100 depending on the prescriber and service.

Quick Answer: Push Health is a clinician-to-patient marketplace; TrimRx is a structured GLP-1 weight loss program

The model is direct-to-clinician rather than program-based. You search by service type and state, request a consultation, and the provider responds with availability and cost. If approved, the prescription is sent to a pharmacy of your choice.

The flexibility is the point. It also puts the burden on patients to evaluate individual providers and understand pricing differences.

How Does TrimRx Differ Structurally?

TrimRx is a packaged weight loss program. You complete an assessment quiz, the platform reviews your intake, and you’re matched with a clinician who follows the program’s titration and care protocols. Pricing is set by the platform, not by individual prescribers.

Medication is compounded and shipped monthly. Side effect coaching, dose adjustment workflows, and the patient portal are standardized. The program is built specifically for GLP-1 therapy continuity over 12 to 24 months.

For patients who want a defined path and predictable cost, that structure is the appeal. For patients who want to shop clinicians, it’s a constraint.

What Medications Does Each Platform Support?

Push Health supports a broad list of prescriptions depending on the provider. GLP-1 prescriptions through Push Health are typically branded products like Wegovy®, Zepbound®, Ozempic®, or Mounjaro®, filled at the patient’s chosen pharmacy. Compounded options exist but vary by provider and state.

TrimRx prescribes compounded semaglutide and compounded tirzepatide as the core product, shipped from licensed compounding pharmacies. The compounded route bypasses the cash-price wall on branded products that hits Push Health patients without insurance coverage.

The American Society of Health-System Pharmacists’ 2024 analyses confirmed that compounded GLP-1 demand grew substantially in 2023-2024 when branded supply was constrained. That gap drove platform differentiation.

What Does Pricing Look Like at Each?

Push Health pricing is provider-dependent. Visit fees can run $30 to $100. The medication is a separate pharmacy charge. For branded Wegovy at retail cash price, monthly cost is roughly $1,349. For Zepbound, around $1,060 through manufacturer DTC or higher at retail. Insurance can apply.

TrimRx pricing is set at the platform. Compounded semaglutide programs typically run $200 to $300 monthly. Compounded tirzepatide runs $300 to $400 monthly. The medication, clinician review, and ongoing portal access are included. There’s no separate pharmacy charge or visit fee.

For uninsured patients, the math favors TrimRx by a wide margin. For insured patients with strong GLP-1 coverage, Push Health with a $25 copay at pharmacy can be cheaper if a good-fit provider is available.

How Does the Provider Relationship Work in Each?

Push Health gives you a single clinician per request, and you typically build a relationship with that prescriber over time if you continue requesting refills from them. Continuity depends on the individual provider’s availability and platform engagement.

TrimRx assigns a clinician within its team. If your assigned clinician is unavailable, another team member picks up your case using the same chart and program protocols. Continuity is at the program level rather than the individual.

Both approaches have trade-offs. A strong individual relationship through Push Health can be excellent if your prescriber is consistent and engaged. Team-based continuity at TrimRx avoids gaps if a single clinician is out.

How Do Safety and Oversight Compare?

Both platforms use US-licensed clinicians and US-based pharmacies. Push Health verifies provider licenses and runs identity verification on prescribers joining the platform. The pharmacy fulfilling the prescription handles its own regulatory compliance.

TrimRx works with 503A and 503B pharmacies registered with state boards and, in the case of 503B outsourcing facilities, inspected by the FDA. The platform’s clinical protocols are standardized rather than provider-specific.

For prescription safety, the strongest variable is the clinician’s diligence on contraindications and dose titration, which exists on both platforms when providers are engaged.

What About State Licensing Coverage?

Push Health operates in most US states, with provider availability varying by state. Some states have telehealth restrictions that limit which prescribers are active.

TrimRx operates in a defined list of states reviewed continually as licensing expands. If your state isn’t covered, the assessment quiz will say so before any commitment.

Both platforms publish their state availability. Always check before completing an intake.

Key Takeaway: STEP 1 (Wilding et al. 2021 NEJM) showed 14.9% weight loss with semaglutide; SURMOUNT-1 (Jastreboff et al. 2022 NEJM) showed 20.9% with tirzepatide

How Does Follow-up Care Differ?

Push Health follow-up depends on the provider. Some prescribers are responsive on messaging, set follow-up cadence, and proactively check in on adherence. Others handle requests transactionally and expect the patient to initiate follow-up.

TrimRx builds follow-up into the program. Dose escalation steps trigger portal check-ins. Side effect questions go through the messaging portal with a documented response time target. Lab orders, when needed, are integrated.

The SUSTAIN trials and the STEP program demonstrated that titration support improves adherence to GLP-1 therapy. Structured follow-up is a feature, not just a service.

Who Should Pick Push Health?

Push Health fits patients who want clinician choice, have a specific provider relationship in mind, are comfortable evaluating providers themselves, and either have insurance coverage that handles the medication cost or are willing to pay retail.

It also fits patients seeking a one-time prescription for travel medications, certain refills, or specific lab orders outside the weight loss category. The marketplace structure works well for patients who know what they want.

Who Should Pick TrimRx?

TrimRx fits patients whose primary goal is sustained weight loss with GLP-1 therapy, want predictable monthly pricing, prefer a structured program over shopping individual providers, and want compounded medication shipped to their home.

The program is designed for the 12 to 24 month treatment timeline that GLP-1 therapy typically requires. Patients who want continuity through dose changes and side effect management benefit from the program structure.

What Does the Broader GLP-1 Evidence Base Show?

Beyond platform specifics, the underlying evidence for GLP-1 therapy is substantial. The STEP program (Wilding et al. 2021 NEJM and follow-up trials) established semaglutide 2.4 mg as effective for weight loss with 14.9% mean reduction at 68 weeks. The SURMOUNT program (Jastreboff et al. 2022 NEJM) showed tirzepatide 15 mg achieving 20.9% reduction at 72 weeks.

Cardiovascular outcomes data adds context. SELECT (Lincoff et al. 2023 NEJM) showed a 20% reduction in major adverse cardiovascular events with semaglutide in patients with obesity and preexisting cardiovascular disease. FLOW (Perkovic et al. 2024 NEJM) demonstrated kidney and cardiovascular benefits in chronic kidney disease patients with type 2 diabetes.

The molecule is what drives outcomes. Platform choice affects access, cost, and support, but not the fundamental pharmacology.

How Do Platform-level Outcomes Track Drug-level Evidence?

Patient-reported outcomes on telehealth platforms often track the trial data when adherence holds and doses reach maintenance. A 2023 JAMA Network Open analysis (Anderson et al.) found telehealth GLP-1 prescribing produced clinical outcomes comparable to in-person care under structured titration protocols.

Real-world weight loss commonly varies more than trial-population weight loss because adherence is less controlled. Patients who reach maintenance dose and stay on therapy for 12 or more months tend to approach trial-level outcomes. Patients who drop out during titration see smaller effects.

This pattern holds across platforms. The structural differences between providers affect access and cost more than they affect clinical outcomes when the same molecule is delivered at the same dose.

What Should You Check Before Committing to Either Platform?

Three practical checks before signing up. First, state licensing: confirm the platform you want is licensed in your state. Coverage shifts as licensing expands. Second, current pricing: compare the personalized treatment plan output from each platform’s free assessment quiz. Promotional rates shift over time. Third, your insurance situation: if you have strong commercial coverage of branded GLP-1s, the math may favor a branded prescription with insurance applied at a retail pharmacy over either platform.

The 2024 American Gastroenterological Association obesity pharmacotherapy guideline continues to support GLP-1 receptor agonists as first-line agents for chronic obesity management. The clinical case is established; the choice of access path is where patients differentiate.

Bottom line: Push Health requires you to evaluate individual providers; TrimRx assigns a clinician within its program

FAQ

Does Push Health Prescribe Compounded GLP-1s?

Some Push Health providers prescribe compounded semaglutide or tirzepatide where state laws and provider licensing allow. Availability and pricing vary by provider. TrimRx makes compounded the core offering and standardizes pricing.

Can I See the Same Push Health Provider Every Time?

You can request the same provider for repeat consultations if they’re available. The marketplace structure doesn’t guarantee continuity if the provider’s availability changes.

Is TrimRx Cheaper Than Push Health?

For uninsured patients on a 12-month GLP-1 treatment plan, TrimRx is dramatically cheaper than Push Health with branded medication at retail. For insured patients with strong GLP-1 coverage, the comparison gets closer and depends on the Push Health provider’s visit fee.

Does Either Platform Accept Insurance?

TrimRx is cash-pay and doesn’t bill insurance. Push Health providers don’t bill insurance for their visit fee. The pharmacy filling a Push Health prescription can apply insurance at pickup.

What States Does Each Platform Cover?

Both platforms operate in most states with some exclusions. State coverage changes as licensing expands. Each platform’s site lists current coverage at intake.

How Do I Switch From Push Health to TrimRx?

Complete the TrimRx assessment quiz, upload any records from your Push Health provider, and time your last Push Health refill so you have a 7 to 14 day buffer before your first TrimRx shipment arrives.

Which Is Better for Long-term Weight Maintenance?

Long-term maintenance benefits from program structure. TrimRx’s standardized titration and follow-up is designed for that timeline. Push Health can work if your individual provider is engaged and consistent, but the marketplace isn’t built around long-term programs.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.